Our Team

For over a-decade our core team has been building an International Leadership Network.

Meet our exceptional core team who possess deep domain expertise in life-science focused start-up evaluation and funding. Our expanded leadership represent a diverse and inclusive council for governance who will be able to provide region specific logistical and cultural perspective.

Linkedin

Copyright 2024 © All rights Reserved.

Copyright 2024 © All rights Reserved.

Dr. Himabindu Gaddipati
Follow on linkedin

Dr. Himabindu Gaddipati, MD, EMTM

Founder and Managing Partner

Dr. Gaddipati is a clinical oncologist and geneticist with over 2 decades of experience in clinical, scientific, regulatory and commercialization aspects of cancer product development. Throughout her career she has strived to understand the critical gaps along the lifecycle. Through her entrepreneurial ventures Lumiseek Inc and VCR Park she has validated the mechanism for creating exponential value by alignment of key resources, infrastructure and expertise across the value chain.

James Tai
Follow on linkedin

James Tai, MBA, MS

James has a diverse life sciences & healthcare background that
spans over two decades which includes life sciences venture
capital, outpatient provider services, healthcare private equity,
and strategy consulting. He sits on the Board of Directors for a
variety of innovative life sciences & healthcare companies, and
has the opportunity to present at national healthcare
conferences.

Follow on linkedin

Dr. Ariane M. Davison, PhD

Senior Investment and Strategic Advisor

Dr. Ariane M. Davison is an immunologist, virologist and molecular geneticist with comprehensive experience in the global healthcare, biotechnology, start-up, consulting and equity industries. She has held key operational and business development roles at venture-backed oncology and device companies in Hong Kong, Singapore, the US, and held investment advisory and asset management roles. She has first-hand experience in the complete value chain processes to asset development, commercialization, FDA and international regulatory approvals. She has a strong focus on M&A vs IPO, emerging market policies and market entry.  In 2013 she was selected for the Kauffman Fellows Venture Capital Fellowship. Ariane earned her Doctorate in Medicine from the University of Sydney School of Medicine on scholarship. Her work has been published in international journals, textbooks, and spoken by invitation at numerous international medical and investment conferences.

Dr. Mandar Kulkarni
Follow on linkedin

Dr.Mandar Kulkarni, PhD

Co-Founder and General Partner

Dr. Kulkarni has acquired life science focused strategic and business development experience over the tenure of his career spanning two decades. He was an executive team member of a seed stage start-up in New Haven which was followed by leadership roles in several precision oncology companies in India where he routinely collaborated with leading institutions across the country.

Dr. Cyrus
Follow on linkedin

Dr. Cyrus Arman, PhD

Strategic Venture Advisor

Dr. Cyrus is a Life Science and Biotechnology executive with 2 decades of expertise in corporate strategy and fund raising. He was a Co-Founder and Managing Partner for BioVega Capital, an event-driven life sciences hedge fund and Vice President, Corporate Development and Strategy for Neuvogen, Inc. Prior to which he served as the director for corporate strategy at Amgen.

Follow on linkedin

Larry Stambaugh, BBA

Senior Strategic Advisor

Mr. Stambaugh is known for his visionary leadership in innovation and high-growth businesses. During his more than 40-year career Mr. Stambaugh’s visionary leader has built successful management teams around his ability to awaken the leader within his associates to have them achieve extraordinary results. Mr. Stambaugh has raised over $500 million of capital in private and public financing. He has taken a company public in both the U.S. and Europe. He has completed several strategic partnerships with Fortune 100 and other companies. As the founding principal at Apercu Partners, he currently serves as Chairman of selected entrepreneurial companies and mentor/coach to CEO’s and boards.

Zoya
Follow on linkedin

Zoya Brar

Strategic Venture Advisor

Zoya Brar founded CORE Diagnostics, a high-end clinical laboratory, focused on bringing innovation to the diagnostic industry, in 2012 when she was 23 years old. She scaled CORE to 500+ employees and served 30 million patients in 13 countries. CORE is now a leading genetic diagnostics player in Southeast Asia.

In 2020, she transitioned the CEO role to her successor (who she trained over seven years) and moved to Vancouver. She continues to be an Executive Advisor to CORE.

She now works with many startups in Canada & the US in a mentor and advisory capacity. Additionally, she works with a women’s health startup in Montreal as Chief of Staff to the CEO. She has also helped Quest Diagnostics reimagine their leadership training programs.
 
Rania Azmi, PhD
Follow on linkedin

Rania Azmi, PhD

Advisor, Investment Committee

Leading “Fadia Survive & Thrive” International Cancer Association, which is a member of the UICC, ABC Global Alliance, and World Patients Alliance, Dr. Azmi has been a patient advocate for over ten years. Fadia Association’s work includes cancer patient advocacy; cancer prevention and control; supporting and alleviating cancer therapy side effects, while focusing on improving patients’ quality of life by putting evidence-based knowledge into practice. In all this, Fadia Association keeps a special focus on those with metastatic cancer, it works on simplifying scientific information for the public, running prevention campaigns, publishing advocacy issues in scientific journals, presenting in international cancer conferences, among other activities. Dr. Azmi is also an Advocate in Science with Komen and member of Komen’s peer review committees of basic, translational and clinical postdoctoral fellowship award.

Besides her cancer volunteering life, Dr. Azmi is a global decision-making expert, where she was chosen by the Asset International Magazine as one of the brightest “forty under forty” stars among the world’s top chief investment officers and was designated a “Woman of Influence” by the Women Speakers Association. She founded “Alexandrite Decision” firm after over two decades of first-hand experience supporting strategic and operational decision making in large institutional investors, Sovereign Wealth Funds and family businesses. Rania is a member of the executive education board at the Wharton School of the University of Pennsylvania and the Aspen Global Leadership Network. She received her Doctorate in Multiple-Objectives Decision Making from the University of Portsmouth.

VK Gadi, MD PhD
Follow on linkedin

VK Gadi, MD PhD

Advisor, Investment Committee

Dr. VK Gadi is a physician and researcher in the Division of Hematology & Oncology at UI Health. As a medical oncologist, Dr. Gadi is focused on providing expert care to eliminate breast cancer of all stages. He practices “precision medicine” by delivering the right drug to the right patient with the fewest side effects possible. As a researcher, Dr. Gadi develops and conducts clinical trials of new medicines, diagnostic tools, and supportive care to improve outcomes for patients with breast and other types of cancers, and his laboratory has made critical discoveries in cancer biology, immunology, and diagnostics.

CS Pramesh, PhD
Follow on linkedin

CS Pramesh, PhD

Senior Advisor, Scientific Committee

He is the convener for the National Cancer Grid, a large network of over 170 cancer centers in India. Dr. Pramesh is highly committed to efforts towards reducing inequities in cancer care and making cancer treatment accessible to all geographic regions and strata of society. He is also a visiting professor at the Division of Cancer Studies, King’s College London and the Institute of Cancer Policy, King’s Health Partners, London. He has written more than 200 peer-reviewed journal articles, abstracts and book chapters on topics in his specialty.

Dr. Pramesh began his training at the Coimbatore Medical College. He completed a residency in general surgery at the King Edward Memorial Hospital and a residency in surgical oncology at the Tata Memorial Centre. Furthering his professional training, Dr. Pramesh completed the Post Graduate Diploma in Clinical Trials at the University of London.